{"data":{"id":"us-me/32-m.r.s.-13844","jurisdiction":"us-me","citation":"32 M.R.S. §13844","heading":"Conditions or diseases managed; scope of practice","body":"1.  Generally accepted standards of care.  A pharmacist may engage in collaborative drug therapy management pursuant to a collaborative practice agreement only for conditions or diseases with generally accepted standards of care.\n2.  Prohibition.  A pharmacist who is engaged in collaborative drug therapy management pursuant to a collaborative practice agreement may not, as part of the collaborative practice, participate in research or clinical or investigational trials.\n3.  Limitation.  A collaborative practice agreement may include only the conditions or diseases to be managed that meet the qualifications and scope of practice for each party to the agreement.","path":["TITLE 32: PROFESSIONS AND OCCUPATIONS","CHAPTER 117: MAINE PHARMACY ACT","SUBCHAPTER 14: COLLABORATIVE DRUG THERAPY MANAGEMENT"],"source_url":"https://legislature.maine.gov/statutes/32/title32sec13844.html","current_through":"October 1, 2025","vintage":"","retrieved_at":"2026-09-04T15:12:37Z","sha256":"72d3eb66774b4af464d9f15921e85ae4462ff16cb5ba8f55857a2fc64bf00f5e","source_id":"us-me","stale":false,"prev":"us-me/32-m.r.s.-13843","next":"us-me/32-m.r.s.-13845"},"notice":"GroundRules: Original legal text. Not legal advice."}